Hall Susan
Insider CIK 1542052 · ENDP EVP, CSO, Global Head of R&D · VRX Global Head of R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENDP Endo International plc | F Tax w/h | 2016-03-11 | 2016-03-14 | 626 | $41.67 | $26.1K | 4,826 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2016-02-24 | 2016-02-25 | 239 | $49.85 | $11.9K | 3,160 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2016-02-23 | 2016-02-25 | 22,481 | — | $0 | 22,481 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-02-23 | 2016-02-25 | 6,665 | — | $0 | 14,180 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-02-23 | 2016-02-25 | 13,331 | — | $0 | 27,071 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-11-11 | 2015-11-12 | 1,000 | — | $0 | 13,740 | SEC↗ |
| ENDP Endo International plc | P Buy | 2015-11-11 | 2015-11-12 | 1,000 | $55.35 | $55.4K | 2,666 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2015-03-11 | 2015-03-13 | 626 | $89.44 | $56.0K | 1,666 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2015-02-24 | 2015-02-26 | 10,823 | — | $0 | 10,823 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-02-24 | 2015-02-26 | 5,865 | — | $0 | 12,740 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-02-24 | 2015-02-26 | 2,932 | — | $0 | 9,807 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-07-26 | 2013-07-30 | 5,173 | — | $0 | 15,521 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-07-26 | 2013-07-30 | 2,500 | — | $0 | 27,588 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-07-26 | 2013-07-30 | 5,173 | — | $0 | 30,088 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-05-31 | 2013-06-04 | 20,694 | — | $0 | 20,694 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-05-31 | 2013-06-04 | 9,203 | — | $0 | 24,915 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-05-31 | 2013-06-04 | 20,694 | — | $0 | 34,118 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-04 | 2012-10-04 | 8,672 | — | $0 | 13,424 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-09-26 | 2012-09-28 | 20,694 | — | $0 | 20,694 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-09-26 | 2012-09-28 | 20,694 | — | $0 | 22,096 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-04-12 | 2012-04-16 | 2,313 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-04-12 | 2012-04-16 | 2,313 | — | $0 | 2,313 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-04-12 | 2012-04-16 | 911 | — | $0 | 1,402 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-03-07 | 2012-03-08 | 16,120 | — | $0 | 32,240 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2012-03-07 | 2012-03-08 | 16,120 | $54.50 | $878.5K | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-03-07 | 2012-03-08 | 16,120 | $13.24 | $213.4K | 16,120 | SEC↗ |